The definition of multiple system atrophy: A review of recent developments

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 12, 1998, Pages 1099-1111

  Lantos, Peter L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Glial cytoplasmic inclusions; Multiple system atrophy; Parkinsonism; Synuclein; Tau protein

Indexed keywords

CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SHY DRAGER SYNDROME;

EID: 0031774904     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199812000-00001     Document Type: Review

References (100)

1. Déjerine J, Thomas AA. L'atrophie olivo-ponto-cerebelleuse. Nouv Iconog Salpêtrière 1900;13:330-70
2. van der Eecken H, Adams RD, van Bogaert L. Striopallidal-nigral degeneration. An hitherto undescribed lesion in paralysis agitans. J Neuropathol Exp Neurol 1960;19:159-61
3. Adams RD, van Bogaert L, van der Eecken H. Dégénérescences nigro-striées et cerebello-nigro-striées. Psychiat Neurol 1961;142: 219-59
4. Shy GM, Drager GA. A neurologic syndrome associated with orthostatic hypotension. Arch Neurol 1960;2:511-27
5. Bradbury S, Eggleston C. Postural hypotension: Autopsy on a case. Am Heart J 1927;3:105-6
6. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34
7. Quinn N .Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworths 1994;3:262-81
8. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy 1998. Neurology (in press)
9. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52:78-89
10. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;495:1284-88
11. Trenkwalder C, Schwarz J, Gebhard J, et al. Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Arch Neurol 1995;52:1017-22
12. st ed. 1982:267-83
13. Gosset A, Pelliser JF, Delpuech F, Khali R. Dégénérescence striato-nigrique associée à une atrophie olivo-pontocérébelleuse. Rev Neurol 1983;139:125-39
14. Wenning GK, Ben Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-45
15. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord 1997;12:133-47
16. 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-56
17. Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990;174:693-96
18. Konagaya M, Konagaya Y, Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. J Neurol Neurosurg Psychiatry 1994;57:1528-31
19. Klockgether T, Schulz JB, Bürk K, et al. Magnetic resonance imaging volumetry in multiple system atrophy. Mov Disord 1997; 12:825
20. Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65-71
21. Schwarz J, Weis S, Kraft E, et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996;60:98-101
22. Lang AE, Curran T, Provias J, Bergeron C. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Can J Neurol Sci 1994;21:311-18
23. Rinne JO, Burn DJ, Mathias CJ, Quinn NP, Marsden CD, Brooks DJ. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol 1995;37: 568-73
24. Brooks DJ. PET in multiple system atrophy. Mov Disord 1997; 12:826
25. Antonini A, Leenders KL, Vontobel P, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997;120:2187-95
26. th ed. 1997;2:281-366
27. Wenning GK, Ben-Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-66
28. Kume A, Takahashi A, Hashizume Y. Neuronal cell loss of the striatonigral system in multiple system atrophy. J Neurol Sci 1993; 117:33-40
29. Kume A, Takahashi A, Hashizume Y, Asai J. A histometrical and comparative study on Purkinje cells loss and olivary nucleus cell loss in multiple system atrophy. J Neurol Sci 1991;101:178-86
30. Tsuchiya K, Watabiki S, Sano M, et al. Distribution of cerebellar conical lesions in multiple system atrophy: A topographic neuropathological study of three autopsy cases in Japan. J Neurol Sci 1998;155:80-85
31. Nakamura S, Ohnishi K, Nishimura M, et al. Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy. Neurology 1996;46:1693-96
32. Ozawa T, Oyanagi K, Tanaka H, et al. Suprachiasmatic nucleus in a patients with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma. J Neurol Sci 1998;154:116-21
33. Kato S, Oda M, Hayashi H, et al. Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis. J Neurol Sci 1995;132:216-21
34. Noda K, Katayama S, Watanabe C, Yamamura Y, Nakamura S. Decrease of neurons in the medullary arcuate nucleus of multiple system atrophy: Quantitative comparison with Parkinson's disease and amyotrophic lateral sclerosis. J Neurol Sci 1997;151:89-91
35. Gray F, Vincent D, Hauw JJ. Quantitative study of lateral horn cells in 15 cases of multiple system atrophy. Acta Neuropathol 1988;75:513-18
36. Terao S, Sobue G, Hashizume, et al. Disease specific pattern of neuronal cell loss in the ventral horn in amyotrophic lateral sclerosis, multiple system atrophy and X-linked bulbospinal neuronopathy, with special reference to loss of small neurons in the intermediate zone. J Neurol 1994;241:196-203
37. Benarroch EE, Smithson IL, Low PA, Parisi JE. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple system atrophy with autonomie failure. Ann Neurol 1998; 43:156-63
38. Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H. Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy. Acta Neuropathol 1996;91:145-54
39. Pramstaller PP, Wenning GK, Smith SJM, Beck RO, Quinn NP, Fowler CJ. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;458:618-21
40. Blin O, Desnuelle C, Rascol O, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125:95-101
41. Spargo E, Papp MI, Lantos PL. Decrease in neuronal density in the cerebral cortex in multiple system atrophy. Eur J Neurol 1996; 3:450-56
42. Holmberg B, Rosengren L, Karlsson JJ, Johnels B. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov Disord 1998;13:70-77
43. Probst-Cousin S, Rickert CH, Schmid KW. Gullotta F. Cell death mechanisms in multiple system atrophy. J Neuropathol Exp Neurol 1998;57:814-21
44. de la Monte SM, Sohn YK, Ganju N, Wands JR. p53-and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 1998;78:401-11
45. Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997;48:384-93
46. Klockgether R, Lüdtke R, Kramer B, et al. The natural history of degenerative ataxia: A retrospective study in 466 patients. Brain 1998;121:589-600
47. Gu M, Gash MT, Cooper JM, et al. Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997;12: 418-22
48. Dexter DT Jenner P, Schapira AHV, Marsden CD. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 1992;32: S94-S100
49. Kato S, Meshitsuka S, Ohama E, Tanaka J, Llena JF, Hirano A. Increased iron content in the putamen of patients with striatonigral degeneration. Acta Neuropathol 1992;84:328-30
50. Wenning GK, Wagner S, Daniel S, Quinn NP. Multiple system atrophy: sporadic or familial? Lancet 1993;342:681
51. Iwahashi K, Miyatake R, Tsuneoka Y, et al. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:263-64
52. Bandmann O, Wenning GK. Quinn NP, Harding AE. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;59:557
53. Bandmann O, Sweeny MG, Daniel SE, et al. Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration. Neurology 1997;49:1598-604
54. Cairns NJ, Atkinson PF, Kovács T, Lees AJ, Daniel SE, Lantos PL, Apolipoprotein E e4 allele frequency in patients with multiple system atrophy. Neurosci Lett 1997;221:161-64
55. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100
56. Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992;107:172-82
57. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-43
58. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morph Acad Sci Hung 1971;19:1-8
59. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994; 57:129-3360
60. Chin S-M, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55:499-508
61. Lantos PL. Multiple system atrophy. Brain Pathol 1997;7:1293-97
62. Kato S, Nakamura H. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructural studies. Acta Neuropathol 1990;79:584-94
63. Arima K, Murayama S, Mukoyama M, Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1 Neuronal cytoplasmic inclusions. Acta Neuropathol 1992;83:453-60
64. Murayama S, Arima K, Nakazato Y, Satoh J-i, Oda M, Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2 Oligodendroglial cytoplasmic inclusions. Acta Neuropathol 1992;84:32-38
65. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: A comparative study and review. Ann Neurol 1996;40:139-48
66. Nakazato Y, Yamazaki H, Hirato J, Ishida Y. Yamaguchi H. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990;49:521-30
67. Kato S, Nakamura H, Hirano A, Ito H, Llena JF, Yen S-H. Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy). Acta Neuropathol 1991;82:488-93
68. Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano M, Matsushita M. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: A correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 1997;93:585-91
69. Abe H, Yagishita S, Amano N, Iwabuchi K, Hasegawa K, Kowa K. Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study. Acta Neuropathol 1992; 84:273-77
70. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-8
71. Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos PL. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett 1997;230:49-52
72. Cairns NJ, Mackay D, Daniel SE, Lantos PL. Tau-pathology of oligodendroglial inclusions in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration. (Abstract) Neuropathol Appl Neurobiol. 1998;24:131
73. Takeda A, Arai N, Komori T, Iseki E, Kato S, Oda M. Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1997;234:63-66
74. Arai N, Nishimura M, Oda M, Morimatsu Y, Ohe R, Nagatomo H. Immunohistochemical expression of microtubule-associated protein 5 (MAPS) in glial cells in multiple system atrophy. J Neurol Sci 1992;109:102-6
75. Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J. Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy. J Neuropathol Exp Neurol 1998;57:690-98
76. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998;249:180-82
77. Gai WP, Power JHT, Blumbergs PC, Blessing WW. Multiple-system atrophy: A new α-synuclein disease? Lancet 1998;352:547-48
78. Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ. Alpha synuclein in neurodegenerative disorders: Murderer of accomplice? Nature Medicine 1998;4:755-57
79. Tamaoka A, Mizusawa H, Mori H, Shoji S. Ubiquitinated α B-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy. J Neurol Sci 1995;129: 192-98
80. Lantos PL. Neuropathological diagnostic criteria of multiple system atrophy: A review. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, eds. Neuropathological diagnostic criteria for brain banking. Amsterdam: IOS Press 1995;116-21
81. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992;340:186
82. Arai N, Papp MI, Lantos PL. New observation on ubiquitinated neurons in the cerebral cortex of multiple system atrophy (MSA). Neurosci Lett 1994;182:197-200
83. Takeda A, Arai N, Komori T, Kato S, Oda M. Neuronal inclusions in the dentate fascia in patients with multiple system atrophy. Neurosci Lett 1997; 227:157-60
84. Gilman S, Sima AAF, Junck L, et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 1996;39:241-55
85. Sima AAF, D'Amato C, Foster NL, Lynch T, Defendini RF, Wilhelmsen KC. Neuronal and glial inclusions in familial progressive limbic lobe sclerosis. J Neuropathol Exp Neurol 1995;54:459
86. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial filaments. Proc Natl Acad Sci USA 1997;94:4113-18
87. Sima AAF, Defendini R, Keohane C, et al. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996;39:734-43
88. Braak H, Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989;15:13-26
89. Daniel SE, Geddes JE, Revesz T. Glial cytoplasmic inclusions are not exclusive to multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:262
90. Foster NL, Wilhelmsen K, Sima AA, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997;41:706-15
91. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388: 839-40
92. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal Accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998;152:367-72
93. Lynch T, Sima AAF. Glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 1996;39:416
94. Iwatsubo T, Hasegawa M, Ihara Y. Neuronal and glial tau-positive inclusions in diverse neurologie diseases share common phosphorylation characteristics. Acta Neuropathol 1994;88: 129-36
95. Wakabayashi K, Oyanagi K, Makifuchi T, et al. Corticobasal degeneration: etiopathological significance of cytoskeletal alterations. Acta Neuropathol 1994;87:545-53
96. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995;146:1388-96
97. Mori H, Nishimura M, Namba Y. Oda M. Corticobasal degeneration: A disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 1994;88:113-21
98. Ikeda K, Akiyama H, Kondo H, Haga C A study of dementia with argyrophilic grains. Possible cytoskeletal abnormality in dendrospinal portion of neurons and oligodendroglia. Acta Neuropathol 1995;89:409-14
99. Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 1994;174:157-59
100. Quinn N, Daniel S. Differences between multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1996;40:945-46